Patents by Inventor John Montague

John Montague has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11974868
    Abstract: X-ray procedure tables with improved structural strength that enable radiation shielding and integrated medical device and monitoring systems. The design allows the incorporation of an integrated patient support structure, radiation shielding and associated devices and conduits for medical care in procedures that employ X-ray imaging. The X-ray procedure table may be formed from a sled table attachable to a pedestal, with at least one side member extending along a bottom of the sled table to add structural rigidity.
    Type: Grant
    Filed: July 27, 2022
    Date of Patent: May 7, 2024
    Assignee: Egg Medical, Inc.
    Inventors: Robert F. Wilson, John P. Gainor, James Montague, Uma S. Valeti
  • Publication number: 20240099673
    Abstract: A transparent radiation shield, attachable to a patient support platform, and movable to shield a physician from imaging radiation, includes a transparent computer display that is controllable to provide a data overlay on the shield pertaining to patient data and/or x-ray images.
    Type: Application
    Filed: December 7, 2023
    Publication date: March 28, 2024
    Applicant: Egg Medical, Inc.
    Inventors: Robert F. Wilson, John P. Gainor, James Montague, Uma S. Valeti
  • Patent number: 11924035
    Abstract: Systems and methods are provided for providing continuous configuration deployment. A configuration definition object may be obtained from a remote datastore. The obtained configuration definition object may be stored in a local datastore. The configuration definition object may be obtained and stored in advance of a scheduled maintenance. The configuration definition object may be obtained in response to the configuration definition object being committed to the remote datastore. The configuration definition object may be used to generate different configuration objects. A configuration object may be generated from the configuration definition object and one or more system characteristics. A service request may be received, and the configuration object may be executed to perform a configuration of a computing system.
    Type: Grant
    Filed: July 12, 2022
    Date of Patent: March 5, 2024
    Assignee: Palantir Technologies Inc.
    Inventors: Nicholas Hall, Hamza Muraj, Jason Free, John Montgomery, James Schweiger, Matthew Levan, Thomas Montague
  • Patent number: 11868728
    Abstract: Techniques for providing and implementing a single skill associated with custom functionality and system-provided functionality are described. The skill may be used to invoke functionality in response to a user input without requiring a user remember exact formulations to cause the functionality to be performed. The skill may be associated with more than one domain. For example, the skill may be associated with custom sample user inputs (corresponding to the custom functionality) that correspond to a custom domain while the skill may also be associated with system-provided sample user inputs (corresponding to the system-provided functionality) associated with a non-custom domain.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: January 9, 2024
    Assignee: Amazon Technologies, Inc.
    Inventors: Jeffery Alan Meissner, Ernesto Gonzalez, Nikhil Mehta, Anemona Oana Hagea, John Montague Howard
  • Publication number: 20230419957
    Abstract: Described are techniques for linking generating a skill-stored user profile, and linking same with a natural language processing (NLP) system-stored user profile. In at least some examples, a user may provide a natural language input to a NLP system. The NLP system may determine a skill is to process to perform an action responsive to the natural language input. To perform the action, the skill may require the user have a user profile stored by the skill, but the user may not have such a user profile. However, the NLP system may store a user profile for the user. The NLP system may determine the user profile stored thereby and may send, with user permission, information in the user profile to the skill. The skill may use the received information to generate and store a user profile for the user. Thereafter, the skill may provide the NLP system with a user profile identifier that the skill may use to identify the user's profile stored thereby.
    Type: Application
    Filed: September 14, 2023
    Publication date: December 28, 2023
    Inventors: Fabien Hertschuh, Mohit Mittal, John Montague Howard, Akshit Proothi, Rahul Manne
  • Patent number: 11810555
    Abstract: Described are techniques for linking generating a skill-stored user profile, and linking same with a natural language processing (NLP) system-stored user profile. In at least some examples, a user may provide a natural language input to a NLP system. The NLP system may determine a skill is to process to perform an action responsive to the natural language input. To perform the action, the skill may require the user have a user profile stored by the skill, but the user may not have such a user profile. However, the NLP system may store a user profile for the user. The NLP system may determine the user profile stored thereby and may send, with user permission, information in the user profile to the skill. The skill may use the received information to generate and store a user profile for the user. Thereafter, the skill may provide the NLP system with a user profile identifier that the skill may use to identify the user's profile stored thereby.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: November 7, 2023
    Assignee: Amazon Technologies, Inc.
    Inventors: Fabien Hertschuh, Mohit Mittal, John Montague Howard, Akshit Proothi, Rahul Manne
  • Publication number: 20220036892
    Abstract: Described are techniques for linking generating a skill-stored user profile, and linking same with a natural language processing (NLP) system-stored user profile. In at least some examples, a user may provide a natural language input to a NLP system. The NLP system may determine a skill is to process to perform an action responsive to the natural language input. To perform the action, the skill may require the user have a user profile stored by the skill, but the user may not have such a user profile. However, the NLP system may store a user profile for the user. The NLP system may determine the user profile stored thereby and may send, with user permission, information in the user profile to the skill. The skill may use the received information to generate and store a user profile for the user. Thereafter, the skill may provide the NLP system with a user profile identifier that the skill may use to identify the user's profile stored thereby.
    Type: Application
    Filed: August 18, 2021
    Publication date: February 3, 2022
    Inventors: Fabien Hertschuh, Mohit Mittal, John Montague Howard, Akshit Proothi, Rahul Manne
  • Patent number: 11114090
    Abstract: Described are techniques for linking generating a skill-stored user profile, and linking same with a natural language processing (NLP) system-stored user profile. In at least some examples, a user may provide a natural language input to a NLP system. The NLP system may determine a skill is to process to perform an action responsive to the natural language input. To perform the action, the skill may require the user have a user profile stored by the skill, but the user may not have such a user profile. However, the NLP system may store a user profile for the user. The NLP system may determine the user profile stored thereby and may send, with user permission, information in the user profile to the skill. The skill may use the received information to generate and store a user profile for the user. Thereafter, the skill may provide the NLP system with a user profile identifier that the skill may use to identify the user's profile stored thereby.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: September 7, 2021
    Assignee: AMAZON TECHNOLOGIES, INC.
    Inventors: Fabien Hertschuh, Mohit Mittal, John Montague Howard, Akshit Proothi, Rahul Manne
  • Patent number: 9114343
    Abstract: A filtration unit and a method of installing a filtration unit are provided. The rectangular filtration unit includes a filter element for filtering fluid. The frame includes a first portion and a second portion. The frame supports the filter element and the frame defines an opening. A first dimension of the filtration unit measured between the exterior of the first portion and the opening is greater than a second dimension of the filtration unit measured between the exterior of the second portion and the opening. In a further example, the filtration unit is mounted in a top section and a bottom section of a holding frame.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: August 25, 2015
    Assignee: BHA Altair, LLC
    Inventors: Abhijeet Madhukar Kulkarni, Richard Michael Ashley Mann, Philip John Montague, Kevin Anthony Saunders, Stephen David Hiner, Marcus Carr Walters
  • Publication number: 20130074463
    Abstract: A filtration unit and a method of installing a filtration unit are provided. The rectangular filtration unit includes a filter element for filtering fluid. The frame includes a first portion and a second portion. The frame supports the filter element and the frame defines an opening. A first dimension of the filtration unit measured between the exterior of the first portion and the opening is greater than a second dimension of the filtration unit measured between the exterior of the second portion and the opening. In a further example, the filtration unit is mounted in a top section and a bottom section of a holding frame.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 28, 2013
    Applicant: General Electric Company
    Inventors: Abhijeet Madhukar Kulkarni, Richard Michael Ashley Mann, Philip John Montague, Kevin Anthony Saunders, Stephen David Hiner, Marcus Carr Walters
  • Publication number: 20120189556
    Abstract: A pharmaceutical composition comprising an anticholinergic and a steroid, optionally together with a pharmaceutically acceptable excipient, the anticholinergic and the steroid optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: March 29, 2012
    Publication date: July 26, 2012
    Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
    Inventors: Michel PAIRET, Michael P. PIEPER, Christopher John Montague MEADE, Richard REICHL, Christel SCHMELZER
  • Publication number: 20110268668
    Abstract: A process for nebulizing highly concentrated solutions of insulin for administration by inhalation.
    Type: Application
    Filed: July 14, 2011
    Publication date: November 3, 2011
    Inventors: Herbert Lamche, Christopher John Montague Meade, Bernd Zierenberg, Ralph Christian Reimholz
  • Publication number: 20110038806
    Abstract: A pharmaceutical composition comprising a compound of formula 1 wherein X? is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable excipient, the compound of formula 1 and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: October 26, 2010
    Publication date: February 17, 2011
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Christopher John Montague MEADE, Michel PAIRET, Michael P. PIEPER
  • Patent number: 7867987
    Abstract: A pharmaceutical composition comprising a compound of formula 1 wherein X? is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable excipient, the compound of formula 1 and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: January 11, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Christopher John Montague Meade, Michel Pairet, Michael P. Pieper
  • Publication number: 20100330186
    Abstract: A pharmaceutical composition comprising a compound of formula 1 wherein X? is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable excipient, the compound of formula 1 and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: September 3, 2010
    Publication date: December 30, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Christopher John Montague MEADE, Michel PAIRET, Michael P. PIEPER
  • Patent number: 7851483
    Abstract: A pharmaceutical composition comprising: (a) a salt of formula 1 wherein: X? is an anion with a single negative charge; and (b) a steroid 2, processes for preparing such pharmaceutical composition, and their use in the treatment of respiratory complaints.
    Type: Grant
    Filed: April 20, 2006
    Date of Patent: December 14, 2010
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Rolf Banholzer, Helmut Meissner, Gerd Morschhaeuser, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck, Christopher John Montague Meade, Michel Pairet
  • Publication number: 20100310477
    Abstract: A pharmaceutical composition comprising an anticholinergic and at least one additional active ingredient selected from among corticosteroids, dopamine agonistes, PDE-IV inhibitors, NK1-antagonists, endothelin antagonists, antihistamines, and EGFR-kinase inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.
    Type: Application
    Filed: August 13, 2010
    Publication date: December 9, 2010
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. Kg.
    Inventors: Michel Pairet, Michael P. Pieper, Christopher John Montague Meade, Richard Reichl, Christel Schmelzer, Birgit Jung
  • Patent number: 7776315
    Abstract: A pharmaceutical composition comprising an anticholinergic and at least one additional active ingredient selected from among corticosteroids, dopamine agonistes, PDE-IV inhibitors, NK1-antagonists, endothelin antagonists, antihistamines, and EGFR-kinase inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.
    Type: Grant
    Filed: December 8, 2004
    Date of Patent: August 17, 2010
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Michel Pairet, Michael P. Pieper, Christopher John Montague Meade, Richard Reichl, Christel Schmelzer, Birgit Jung
  • Publication number: 20090155185
    Abstract: A pharmaceutical composition comprising an anticholinergic and a betamimetic of formula 2 optionally together with a pharmaceutically acceptable excipient, the anticholinergic and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of asthma, COPD, or other inflammatory or obstructive respiratory complaints.
    Type: Application
    Filed: January 7, 2009
    Publication date: June 18, 2009
    Inventors: Christopher John Montague Meade, Michel Pairet, Michael P. Pieper, Ingo Konetzki
  • Patent number: 7507745
    Abstract: The present invention relates to novel pharmaceutical compositions based on fluorene carboxylic acid ester derived anticholinergics of formula 1 and soluble TNF receptor fusion proteins, processes for preparing them and their use in the treatment of respiratory diseases.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: March 24, 2009
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Christopher John Montague Meade, Michel Pairet, Michael P. Pieper